Metsa Board Oyj Class B METSB

AddLife has had a mixed share-price story in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current price around its recent close really aligned with the cash flows the healthcare supplier is expected to generate? Over the past 3 years, AddLife has delivered a very large return of about 216.5%, which puts a lot of weight on whether its cash generation can sustain that kind of re-rating. The business model leans heavily on recurring...

NHK Spring has seen a powerful share price run over the past few years, which naturally raises the question of whether the current ¥3,467 level is backed up by the cash the business can generate. After such a strong stretch, investors are increasingly asking how much of the recent share performance is explained by the company’s underlying cash flows rather than market enthusiasm alone. Over the last 5 years the stock has returned 381.3%. This places significant focus on whether NHK Spring’s...